UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000028787 |
|---|---|
| Receipt number | R000032946 |
| Scientific Title | Clinical study for advanced or metastatic soft tissue sarcoma of non-extremities treated with doxorubicin-based chemotherapy (a retrospective study) |
| Date of disclosure of the study information | 2017/08/23 |
| Last modified on | 2017/08/23 14:43:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clinical study for advanced or metastatic soft tissue sarcoma of non-extremities treated with doxorubicin-based chemotherapy (a retrospective study)
Acronym
Clinical study for advanced or metastatic soft tissue sarcoma of non-extremitie
Scientific Title
Clinical study for advanced or metastatic soft tissue sarcoma of non-extremities treated with doxorubicin-based chemotherapy (a retrospective study)
Scientific Title:Acronym
Clinical study for advanced or metastatic soft tissue sarcoma of non-extremitie
Region
| Japan |
Condition
Condition
metastatic soft tissue sarcoma of non-extremities treated with doxorubicin-based chemotherapy in our institution
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To reveal the efficacy of the doxorubicin based chemotherapy including monotherapy and combination therapy (CYVADIC, AI, and others) in patients with metastatic soft tissue sarcoma of non-extremities in our institution
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Overall survival for the patients with metastatic soft tissue sarcoma of non-extremities who were treated with doxorubicin based chemotherapy
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
patients with metastatic soft tissue sarcoma of non-extremities who were treated with doxorubicin based chemotherapy between October 2015 and April 2016 in our institution
Key exclusion criteria
not applicable
Target sample size
75
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Shunji Takahashi |
Organization
Cancer Institute Hospital of Japanese Foundation for Cancer Research
Division name
Department of Medical Oncology
Zip code
Address
3-8-31 Ariake, Tokyo, 135-8550
TEL
+81-3-3520-0111
s.takahashi-chemotherapy@jfcr.or.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Shoko Marshall |
Organization
Cancer Institute Hospital of Japanese Foundation for Cancer Research
Division name
Department of Medical Oncology
Zip code
Address
3-8-31 Ariake, Tokyo, 135-8550
TEL
+81-3-3520-0111
Homepage URL
shoko.masharu@jfcr.or.jp
Sponsor or person
Institute
Cancer Institute Hospital of Japanese Foundation for Cancer Research
Institute
Department
Personal name
Funding Source
Organization
Cancer Institute Hospital of Japanese Foundation for Cancer Research
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
YES
Study ID_1
2017-1002
Org. issuing International ID_1
Cancer Institute Hospital of Japanese Foundation for Cancer Research
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 08 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 05 | Month | 22 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 05 | Month | 22 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This is a retrospective study with reviewing patients data
Management information
Registered date
| 2017 | Year | 08 | Month | 23 | Day |
Last modified on
| 2017 | Year | 08 | Month | 23 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032946
